Our mission is to solve FDA Market Surveillance
We deliver critical insights for Risk Signals, Post-market Surveillance, and Emerging Trends.
%20RIGHT%20FIRST%20TIME%20%3D%20DALL%C2%B7E%202023-12-01%2010.10.0.png)
%20DATA%20TO%20ACTIONS%20%3D%20DALL%C2%B7E%202023-12-01%2010.02.11.png)
RISK~1.PNG)
%20INTUITION%20%3D%20DALL%C2%B7E%202023-12-01%2010.18.30.png)
%20USEFULNESS%20%3D%20DALL%C2%B7E%202023-12-01%2010.22.10.png)
5+
Team members
500K
Signals
10M+
Complaints
$0M
Capital raised
Meet the team behind
MAUDE 2.0 - NextGen Market Intelligence & Post-Market Surveillance.
Riskbased.ai - NextGen Risk Analytics for FDA Industries.
Right First Tme
Error-proof with confidence
Data-Driven
Substantiate your approach
Risk-Based
Growth requires adversity
Intuitive
Simple is better
Usefulness
Useful data > big data
Candor
Candor adds value